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Abstract 
Det er økende enighet om at visse kognitive prosesser er kritiske i utvikling og 
opprettholdelse av Alvorlig Depressiv Lidelse (MDD). En ruminerende kognitiv stil har 
vært funnet å kunne predikere både alvorlighetsgrad og kronisitet i MDD og har blitt 
koblet til svakheter i eksekutive funksjoner som inhibisjon og mental fleksibilitet. I 
denne studien ble dette forholdet undersøkt nærmere gjennom en fem-årsoppfølging 
(T3) av førstegangsdeprimerte som tidligere hadde blitt testet ved første episode (T1) og 
ett år senere (T2). Det ble også undersøkt hvorvidt ruminering og/eller inhibisjon kunne 
predikere tilbakefall på T2 og T3. Tredve forsøkspersoner som møtte kriteriene for 
første episode av unipolar MDD og 30 kontrollpersoner ble innlemmet i studien på T1. 
Ruminering og inhibisjon ble målt ved hjelp av Ruminative Response Scale (RRS), 
Rumination Reflection Questionnaire (RRQ) og Color-Word Interference Test fra 
Delis-Kaplan Executive Function System. Resultatene viser en signifikant forskjell 
mellom pasient- og kontrollgruppe bade på ruminering og inhibisjon, som vedvarer over 
tid. Det ble funnet en sammenheng mellom inhibisjon og ruminering på tvers av 
gruppene. Resultatene viste imidlertid ingen sammenheng mellom disse faktorene og 
tilbakefallsrisiko. Det kan slås fast at svekket kognitiv inhibisjon og økt ruminering er 
karakteristiske trekk ved depresjon over tid.   
 
 
 
 
 
 
	   	   	   	   	  
Abstract 
There is growing consensus that certain cognitive processes are critical in the 
development and maintenance of Major Depressive Disorder (MDD). A ruminative 
responsive style has been found to predict both severity and chronicity of MDD and has 
been linked to deficits in executive functions such as inhibition and mental flexibility. 
The present study investigated this relationship further in a five-year follow up (T3) of 
depressed individuals, who had previously been tested at first-episode MDD (T1) and at 
one-year follow up (T2). Whether rumination and/or inhibition could predict relapse at 
T2 and T3 was also studied. 30 subjects meeting the criteria for first-episode unipolar 
MDD and 30 controls were included in the study at T1. Rumination and inhibition was 
measured using the Ruminative Response Scale (RRS), Rumination-Reflection 
Questionnaire (RRQ) and the Color-Word Interference Test (CWIT) of the Delis-
Kaplan Executive Function System. The results show a significant difference between 
patients and controls on both rumination and cognitive inhibition that persists over time. 
A correlation between cognitive inhibition and rumination was found across all 
subjects. However, the results did not show evicence of these factors being related to 
risk for relapse. Thus, impaired inhibition and increased rumination are long lasting 
characteristics in MDD. 
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Inhibiton and rumination in first-episode depressed individuals: A five-year follow-up 
study 
Affecting 350 million people and being the leading cause of disability in the 
world, Major Depressive Disorder (MDD) is a serious threat to public health and 
wellbeing (World Health Organization, 2015). Depressive episodes affect behavior, 
cognition and emotion (Gotlib & Joorman, 2010), with symptoms such as difficulties 
concentrating, loss of interest and energy, and a pessimistic outlook on life (World 
Health Organization, 1992). Depressed individuals have more than twice the likelihood 
to commit suicide compared to the rest of the population (Haddad & Gunn, 2011). 
MDD also causes significant distress in the family and friends of the depressed 
individual, with the bond between romantic partners and parent and child being 
particularly affected (Haddad & Gunn, 2011). Findings from several studies suggest that 
the age of onset for depression is declining (Dalgård & Bøen, 2008), making 
identification and implementation of preventative measures all the more important for 
future generations.  
 In Norway, treatment of depression costs an estimated 1.5 billion kroner each 
year (Dalgård & Bøen, 2008). The lifetime prevalence of depression in Oslo has been 
found to be 17.8 percent, making it the most commonly occurring mental illness in 
Norway alongside alcohol dependency/abuse (Kringlen, Torgersen & Cramer, 2001). 
American epidemiological studies have found several factors that increase the 
likelihood of suffering from depression, including being female, having lower income, 
being unmarried and living in urban areas (Friedman & Anderson, 2009). MDD is 
frequently comorbid with other psychiatric illnesses as well as physical conditions. In a 
worldwide study on chronic illness and depression, Moussavi and colleagues (2007) 
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found that depression was much more prevalent in individuals with a chronic physical 
condition, such as diabetes. They also reported that people suffering from depression or 
depression in combination with a chronic illness had significantly poorer health 
compared to patients suffering only from physical conditions. People suffering from 
asthma, arthritis, diabetes, and cardiovascular disease have been found to be more likely 
to suffer from depression than healthy individuals (Chapman, Perry & Strine, 2005). 
Suffering from depression in addition to a chronic physical condition often has a 
negative impact on the treatment and course of the chronic disease, making screening 
for and treatment of depressive symptoms an important concern (Chapman et al., 2005). 
Kessler and associates (2007) found that 72 percent of people with MDD additionally 
met the criteria for one or more DSM-IV disorders. Anxiety disorders were the most 
frequently co-occurring with MDD, found in over 59 percent of cases, followed by 
impulse control disorders (30%) and substance abuse (24%) (Kessler et al., 2007).  
A troubling aspect of depression, which contributes to the large personal and 
societal costs of the illness, is the high probability for reoccurrence. According to 
epidemiological data, more than 60 percent of people who have their first major 
depressive episode will experience another one, while a person with three previous 
episodes has a 90 percent chance of a new episode occurring (APA, 2000). Once a 
person has been in treatment for a depressive episode, they will in general spend 20 
percent of their remaining life in a depressed state (Coyne, 2000).  The likelihood of 
developing new depressive episodes appears to be greater in individuals who do not 
experience a complete recovery from depressive symptoms (Gopinath, Katon, Russo, & 
Ludman, 2007; Lin et al., 1998). Environmental stressors seem to play a bigger part as a 
precipitating factor in an individual's first and second depressive episode, while being of 
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less significance for the development of subsequent periods of depression (APA, 2000). 
The severity of the first depressive episode also predicts recurrence (APA, 2000). When 
studying previously depressed people perceived by their primary physician as being at 
risk for subsequent episodes, Gopinath and colleagues (2007) found low self-efficacy, 
negative perception of own health and low adherence to medication in the past month to 
be the strongest predictors of relapse. Maj, Veltro, Pirozzi, Lobrace and Magliano 
(1992) found that the strongest predictors for relapse in a five-year period were the 
number of previous episodes, underlying and chronic minor affective disorders, and 
family history of affective disorders respectively. They also found a pattern of 
increasing severity of subsequent episodes of depression (Maj et al., 1992). Patten 
(2013) points out that little research has been done on recurrence in depression, which 
makes evidence-based treatment difficult in long-running therapy.   
Several researchers and theorists have tried to explain why people get depressed, 
and what makes some people more vulnerable to experience multiple depressive 
episodes over their lifespan. According to Beck's cognitive model of depression, our 
pre-existing schemas shape our view of the environment and direct our attention to 
stimuli that are congruent with these schemas (Teasdale, 1988). Thus, a depressed 
person tends to focus on negative aspects of the world because of the negative nature of 
her mental representations, which contain themes such as loss, hopelessness and despair 
(Gotlib & Joormann, 2010). These schemas will also be present when the person is not 
currently in an episode of depression, creating a persistent vulnerability for recurrence 
(Gotlib & Joormann, 2010). Within the framework of a cognitive model of depression, 
biased information processing and recall should also lead to difficulties in emotional 
regulation, as cognition would steer attention towards negative stimuli and memories. 
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Little evidence has been found in support of the hypothesis that depression affects all 
aspects of information processing, but there are strong indications that depressed 
individuals have deficits and biases in specific areas of cognition (Gotlib & Joormann, 
2010). The research findings on the cognitive characteristics of depression will be 
presented in the following.   
 Neuropsychology, Cognition and Depression 
Cognition is a broad term, capturing many different aspects of human 
functioning, and it is widely studied in relation to both normal functioning and mental 
disorders. It can be conceptualized as the internal processes that are involved when we 
make sense of the environment surrounding us and when deciding what action is 
appropriate in relation to the environment (Eysenck & Keane, 2015). Cognitive 
neuroscience is highly related to cognitive psychology, but adds to the study of human 
behavior by also studying the brain when people perform different cognitive tasks 
(Eysenck & Keane, 2015). There is general consensus that cognitive processes are 
closely linked to the development and effective treatment of mental disorders. 
Cognition and cognitive neuropsychology has been studied in relation to affective 
disorders, including depression, and in the following we will present some of the 
relevant research findings in this field of study.   
Neuropsychological structures and depression.  
A great amount of research has been conducted to explain the neurobiology of 
depression and other mood disorders. In 1937, Papez established the importance of the 
“system of emotion” in the brain, which includes major pathways in the limbic system 
including cingulate gyrus, hippocampus, hypothalamus and anterior thalamic nuclei. 
The research has been expanded to include other important areas, particularly the 
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prefrontal cortex (PFC), after the emergence of neuroimaging techniques (Beyer & 
Krishnan, 2002; Drevets, 2000; Videbech, 1997). These areas and their stability or 
malfunction is considered central to the pathophysiology of depression (Palazidou, 
2012). 
The PFC is the most widely studied brain structure in relation to depression, 
along with amygdala and hippocampus (Palazidou, 2012). Studies have shown a 
reduction in brain volume in depressed patients, with large reductions in areas of PFC, 
hippocampus, putamen and caudate (Beyer & Krishnan, 2002; Campbell, Marriott, 
Nahmias, & MacQueen, 2014; Hajek, Kozeny, Kopecek, Alda, & Hoschl, 2008; 
Sheline, Gado, & Kraemer, 2003; Videbech & Ravnkilde, 2004). Research also shows 
abnormalities in blood flow and glucose metabolism in several prefrontal cortical and 
limbic structures assumed to be involved in emotional processing (Drevets, 1998). This 
includes abnormal activation in the amygdala, which correlates with the severity of 
depression (Drevets, Bogers, & Raichle, 2002; MacDonald, Cohen, Stenger, & Carter, 
2000). The PFC has rich connections to subcortical structures, like basal ganglia, but 
also sends and receives projections from nearly all the sensory and motoric cortical 
areas, which makes it well placed and connected in order to integrate higher-level 
representation from, and exert control over, different neurological systems in the brain 
(Gilbert & Burgess, 2008). The PFC seems to play an important role in the coordination 
of emotion and cognition by controlling limbic impulses and making emotional 
reactions appropriate to the situation (Ardila, 2008).  
Hippocampus plays a central role in learning and memory (Squire & Knowlton, 
2000), and a dysfunction in the hippocampus may be responsible for inappropriate 
context-dependent emotional responses (Fanselow, 2000). Hippocampus is closely 
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linked to the hypothalamus (Fanselow, 2000; Squire & Knowlton, 2000), and 
demonstrates a high capacity for neuroplasticity (Eriksson et al., 1998.). Memory 
impairment is seen in both first time depressed patients as well as patients with multiple 
episodes, but only in the latter group is the volume of hippocampus reduced (MacQueen 
et al., 2003; Videbach & Ravnkilde, 2004). It has been suggested that this structural 
abnormality may be a characteristic trait for recurrent depression (Frodl et al., 2004; 
Neumeister et al., 2005). 
Based on the great amount of research done on this area, Palazidou (2012) 
advocates that depressive disorder has a multifactorial aetiopathogeneses, including a 
genetic diathesis, and with stress playing a major role. This includes abnormalities in 
pathophysiological mechanisms, such as reduced activity in the monoamine 
neurotransmission, a reduction in brain neurotrophins, and hyperactivity in the 
hypothalamus-pituitary-adrenal (HPA) axis. These are connected with functional and 
structural abnormalities, affecting the system balance. The hypothesis is that PFC, 
which becomes functionally and structurally impaired, is unable to regulate the 
overactivity within the cortical and limbic regions. This may result in the clinical 
manifestation of the depressive syndrome. Antidepressant drugs may reverse some of 
the structural changes in the hippocampus, and increase monoaminergic 
neurotransmission, and may have a beneficial modulatory effect on the disrupted 
neurobiological and neurostructural functions (Bunny & Davis, 1965, as cited in 
Hirschfeld, 2000; Schildkraut, 1965, as cited in Hirschfeld, 2000). Research on the 
neurobiology of mood disorders is important, as researchers seem to agree that the PFC 
is the neurobiological system that is closest related to executive functioning, though the 
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precise nature of this connection is still not completely understood (Hsu, Novick & 
Jaeggi, 2014).  
In the present study, we investigate the role of rumination and inhibition in 
MDD, processes thought to be rooted in executive functioning. The above-presented 
evidence of unique variations in the brains of patients suffering from depression, can be 
seen in association with the cognitive impairments in MDD that will be explored in the 
following.  
Cognitive functioning and depression.  
Studies on how depressive symptoms affect people’s performance on cognitive 
tasks, have found dysfunctions in attention focus, memory, and aspects of executive 
functioning. When investigating attention focus in depressed individuals, a review by 
Gotlib and Joorman (2010) found that when negative information is presented over an 
extended period of time, depressed people focus on it longer than healthy controls, and 
have problems disengaging from the information even though it is irrelevant to the task 
they are performing. In studies where people were asked to ignore information that was 
either positive or negative, the depressed participants were found to have difficulties not 
paying attention to negative information (Joormann, 2004). Joormann and Gotlib (2008) 
found that depressed individuals are less efficient in removing no-longer relevant 
negative information from working memory compared to people who have never been 
depressed. Gotlib and Joormann (2010) hypothesize that this extended attention focus 
on mood-congruent information can exacerbate depressed states and be an obstacle to 
recovery for people suffering from depression. In their meta-analysis of studies using 
the Cambridge Neuropsychological Test Automated Battery (CANTAB) on currently 
and previously depressed individuals, Rock, Poiser, Riedel and Blackwell (2014) found 
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moderate deficits on attention focus tasks in both depressed and remitted patients. It is 
worth to note that whereas many studies have demonstrated that people suffering from 
anxiety automatically focus on negative stimuli in the environment, no such 
assumptions can be made about depressed people based on the research available today 
(Gotlib & Joormann, 2010). Mathews and Macleod (2005) present several research 
findings that show no automatic attentional bias towards negative stimuli in depressed 
patients when the stimuli is presented too briefly to be processed consciously. 
 Memory is another part of cognition that has been demonstrated to be affected 
by a depressed state. Indeed, in their meta-analysis of mood-congruent memory, Matt, 
Vázquez and Campbell (1992) found that clinically depressed people are prone to 
remembering negative autobiographical information while non-depressed individuals 
have a bias towards remembering positive memories. Another characteristic found in 
memory functioning in depressed people, is over-general remembering. A substantial 
amount of research has found that when asked to recall specific events or memories, 
depressed people to a larger extent than healthy peers come up with generic information 
from long-term memory instead (Williams et al., 2007). This lack in specificity of recall 
is associated with poor problem-solving skills, and also with delayed recovery from 
depressive episodes (Williams et al., 2007). When induced to recall pleasant 
autobiographical information, non-depressed individuals have been found to recover 
from a sad mood (Joormann & Siemer, 2004). People who are dysphoric, however, do 
not experience this effect, a fact that suggests that people who are depressed are unable 
to use positive memories as a way of emotional regulation (Gotlib & Joormann, 2010). 
In the above-mentioned meta-study using CANTAB, currently depressed people had 
moderate impairments in memory tasks, while remitted individuals showed small 
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impairments (Rock et al., 2014).  
Executive functioning can be conceptualized as a collective term for higher-level 
cognitive processes that facilitate new ways of behaving and help guide us in 
approaching new and unfamiliar situations (Gilbert & Burgess, 2008). These processes 
are separate, but closely related, and seen as necessary for the conduction of 
meaningful, goal-oriented behavior, and in planning the future or switching from one 
task or activity to another and when resisting temptations (Gilbert & Burgess, 2008; 
Wagner, Alloy & Abramson, 2015). It includes inhibition, mental flexibility, working 
memory, initiation of action, and the ability to filtrate interference and predict the 
consequences of our behavior among others (Ardila, 2008; Gilberg & Burgess, 2008). It 
has been suggested by many researchers that depression could be associated with a 
reduced capacity in executive processes, and the scientific evidence does support this 
idea to a certain extent (Gotlib & Joormann, 2010). Rock and colleagues (2014), found 
moderate deficits on executive functions in their meta-analysis on currently depressed 
patients, using CANTAB. This includes deficits on visual planning, reasoning and 
impulsivity (Stockings of Cambridge Test), working memory (Spatial Working 
Memory Test, Spatial Span Test) and cognitive flexibility (Intra-Extra Dimensional Set 
Shift). Moderate deficits in executive function were also found when analyzing studies 
on remitted patients (Rock et al, 2014). In the review by Gotlib and Joorman (2010), 
they found evidence for impaired inhibition for both emotionally neutral tasks, and 
emotionally laden tasks, in depressed individuals. Other reviews on the matter have 
added substantial support suggesting that depressed individuals show impairment in 
executive functions, especially inhibition and mental flexibility (Austin, Mitchell & 
Goodwin, 2001; Castaneda, Tuulio-Henriksson, Marttunen, Suvisaari, & Lönnqvist, 
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2008; Hammar & Årdal, 2009). This impairment in inhibition is seen in both first 
episode depressed indivduals (Schmid & Hammar, 2013b), as well as in longitudinal 
studies of recurrent depression (Schmid & Hammar, 2013a).  
In summary, there are several biases in cognition and executive function that 
characterize depression. Once made aware of mood-congruent stimuli, depressed people 
tend to focus on this for an extensive amount of time and are also less able to stop 
thinking about this information when it is no longer relevant to the task they are 
performing. There is also evidence that people suffering from depression have 
difficulties recalling specific autobiographical memories and that they do not experience 
heightened mood when reminded of positive memories. When investigating executive 
functions, researchers have found impairments across several domains, demonstrating a 
profound impairment in abilities to inhibit both emotionally neutral, and emotionally 
laden information, as well as deficits in mental flexibility.   
Rumination  
The response styles theory (RST) presented by Susan Nolen-Hoeksema (1991) 
suggests that the way individuals respond to their depressed mood will affect the 
duration of this mood. A ruminative response style is conceptualized as a repeated focus 
on the depressed mood, the symptoms of depression and their meaning, as well as the 
cause and the consequences of the depression. People who are prone to this way of 
thinking, Nolen-Hoeksema (1991) suggests, will suffer from prolonged periods of 
depressed mood. An example of a ruminative response can for instance be to isolate 
oneself from one’s surroundings in order to think about symptoms and the origin of 
these. An important feature of the RST is that it is the style of the negative cognition, 
and not the content, that is important (Nolen-Hoeksema, 1991). It is also important to 
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distinguish ruminative responses from problem solving. In active problem solving, the 
individual engages in different behaviors with the intention to solve a problem related to 
their depression. People who ruminate, however, do not take action, but spend their time 
only thinking about how they feel (Nolen-Hoeksema, 1991; Nolen-Hoeksema, Morrow 
& Fredrickson, 1993). It has been suggested that it is the focus on the individual’s 
emotion and current state of feeling depressed that is most important, mainly due to the 
fact that most depressions are not related to specific events, but there are still symptoms 
present, which gives the individual something to ruminate about. Further, when 
depressed people focus on their emotional state they are focusing on a negative aspect, 
which again may cause their thinking to be affected by their mood (Nolen-Hoeksema, 
1991). Studies have shown that people who score higher on measures of self-focus also 
tend to take less action, to ruminate more and to be sadder (Wood, Saltzberg, Neale, 
Stone & Rachmiel, 1990). Further, research has supported the hypothesis that response 
styles are consistent over time, as shown by Nolen-Hoeksema and colleagues (1993). 
More recent reviews have found that a ruminative response style appears to predict the 
onset of depression to a larger degree than the length of the depressive episode (Nolen-
Hoeksema, Wisco & Lyubomirsky, 2008). It has further been shown to maintain 
depressed mood (Donaldson & Lam, 2004), predict the severity of a depressive episode 
(Just & Alloy, 1997; Lam, Smith, Checkley, Rijsdijk & Sham, 2003) and the chronicity 
of a depressive disorder (Kuehner & Weber, 1999). Rumination has also been linked to 
low social support (Nolen-Hoeksema, 1991) and comorbid anxiety and depression 
(Nolen-Hoeksema, 2000). Finally, there is emerging evidence that rumination is related 
to an increased relapse risk in individuals who experience depressive mood (Huffziger, 
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Reinhard & Kuehner, 2009; Michalak, Hölz & Teismann, 2011; Nolen-Hoeksema, 
2000).  
The opposite of a ruminative response style is distraction, conceptualized as a 
meaningful attention switch from the depressive symptoms to a neutral or positive 
activity (Nolen-Hoeksema, 1991). An important feature of the RST is that whether 
people engage in either rumination or distraction as a response to depressed mood 
should strongly predict the duration of their negative mood, which according to the 
above-mentioned studies it appears to do.  
Researchers often separate between trait rumination, a stable disposition to 
ruminate, and state rumination, which is the act of ruminating after a single stressful 
event (Just & Alloy, 1997; Key, Campbell, Bacon & Gerin, 2008). In studies, 
researchers often study trait or state rumination by either examining the cognitive 
correlates of scores on self-report measures of trait rumination (e.g. Altamirano, Miyake 
& Whitmer, 2010; Wagner et al., 2015; Whitmer and Banich, 2007; Whitmer and Gotlib 
2013), or by investigating the effect of an experimentally induced state of rumination on 
executive function performance tasks (e.g., Phillipot & Brutoux, 2008; Watkins and 
Brown 2002; Whitmer & Gotlib, 2012). It seems that trait rumination is a quite stable 
tendency, and that there are individual differences in this trait, which are consistent over 
time and across levels of depressive symptoms and the content of ruminative thinking 
(Mandell, Siegle, Shutt, Feldmiller & Thase, 2014; Wagner et al., 2015).  
Originally, rumination was seen as a unitary concept, but research has 
subsequently identified two different forms of rumination: brooding and reflection 
(Mor, Hertel, Ngo, Shachar & Redak, 2014). It is the brooding aspect, a passive, 
preservative, and judgmental focus, of rumination that is seen as maladaptive. 
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Reflection on the other hand is contemplative, intentional wondering about one’s 
current state in order to solve a problem or a challenge (Mor et al., 2014), much like the 
problem solving mentioned previously. Many theorists have proposed that hopelessness 
regarding the future and negative evaluations of the self are core features of depressive 
disorders, and it seems that rumination also contributes to this, according to content 
analysis of rumination (Nolen-Hoeksema, 2000).  
Rumination, Inhibition and Mental Flexibility  
There is increasing evidence and growing consensus that there are cognitive 
processes that appear to be critical in the onset and maintenance of depressive disorders, 
such as the cognitive biases mentioned previously, as well as deficits in executive 
functioning (Joormann & Quinn, 2014). Much research has been conducted in order to 
understand the relationship between trait rumination and clinical depression. From the 
research mentioned above it seems that a ruminative response style affects the 
individual in many different ways, and a growing body of literature suggests that it also 
affects cognition and neuropsychological functioning. Specifically, the concept of 
executive functioning has been linked to rumination (Joormann & Quinn, 2014). There 
is increasing evidence that rumination is connected to deficits in executive functioning, 
specifically when processing emotionally laden information (Wagner et al., 2015).  
 In the relationship between deficits in executive functioning and a tendency to 
ruminate, it is particularly the concepts of inhibition and mental flexibility that have 
been studied. Inhibition can be defined as the ability to intentionally prevent or overrule 
the tendency to use dominant, automatic responses when its either not necessary or 
when they are no longer relevant (Gilbert & Burgess, 2008; Philippot & Brutoux, 2008). 
Mental flexibility can be defined as the ability to change between different stimulus-
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response sets, or between tasks or operations (Gilbert & Burgess, 2008; Philippot & 
Brutoux, 2008). Switching is related to mental flexibility, conceptualized as the 
changing of the attention away from current representation and over to something new 
when the environmental conditions are changing (Whitmer & Gotlib, 2012). In the next 
section, we present studies that have researched the effect of trait and state rumination 
on performance on inhibition and mental flexibility tasks.  
 When examining state rumination and executive functioning, the subjects are 
usually presented with a manipulation that is meant to induce either rumination or 
distraction, before performing tasks involving inhibition or mental flexibility (see 
Morrow & Nolen-Hoeksema, 1990, for the most common rumination/distraction 
manipulation). A study by Whitmer and Gotlib (2012) predicted that induced 
rumination in depressed subjects would show more errors in inhibition and greater 
switching costs than non-depressed controls who were induced to ruminate and 
depressed individuals who were induced to distraction. Their results only partly 
confirmed their predictions, as they were not able to demonstrate that induced 
rumination impaired performance on inhibition tasks in depressed individuals. They did 
however demonstrate that induced rumination affected switching costs in the same 
group. These results suggest that deficits in task switching are dependent on a 
ruminative response style (Whitmer & Gotlib, 2012). Another study investigated 
whether it was only in the dysphoric individuals who were induced to ruminate one 
would see draining of executive resources (Philippot & Brutoux, 2008). In contrast to 
Whitmer and Gotlib’s (2012) study, their results showed a relationship between deficits 
in inhibition and depressive rumination. The dysphoric subjects who were induced to 
ruminate made more errors, displaying a deficit in inhibition, and they also seemed to 
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be less flexible when they were induced to ruminate compared to non-dysphoric 
individuals (Philippot & Brutoux, 2008). They further suggest that flexibility might be 
fundamentally impaired in depressed individuals and that the induced rumination 
appears to exacerbate this tendency. This study replicates the finding of Watkins and 
Brown’s study from 2002. They found that depressed individuals induced to ruminate 
made more errors on a random number-generation task meant to measure inhibition, 
compared to non-depressed subjects induced to rumination, and depressed and non-
depressed people induced to distraction.  
When examining trait rumination, the subjects are measured on one or several 
self-report questionnaires before performing the executive function tasks. The self-
report questionnaires measure the individual level of current rumination, or a general 
tendency to ruminate. Trait rumination seems to be qualitatively distinct from 
rumination, and holds a particular pattern of association with performance on 
emotionally neutral cognitive tasks that also seem to affect the individual’s ability to 
perform on inhibition and inhibition/switching tasks. Davis and Nolen-Hoeksema 
(2000) investigated whether trait ruminators would differ in their performance on the 
Wisconsin Card Sorting Test, a test thought to measure mental flexibility, from non-
ruminators. Their results show that the trait ruminators made more errors of 
perseveration than the non-ruminators, adding to the evidence that rumination might be 
characterized by an inflexible cognitive style (Davis & Nolen-Hoeksema, 2000). Owens 
and Derakshan (2013) found that high ruminators performed poorer on a switching task 
that required them to switch between the former task and over to the new and relevant 
one. The high ruminators showed more interference from the currently irrelevant task 
and poorer filtering, which made them commit more errors compared to low ruminators 
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(Owens & Derakshan, 2013). Thus, their findings also add to research linking mental 
flexibility to impaired inhibition in rumination. They further argue that rumination in 
itself contributes to some of the cognitive deficits found in depression, and that 
impaired inhibition may cause a continuation of the ruminative pattern, even if the 
individual understands its maladaptive effect (Owen & Derakshan, 2013). Whitmer and 
Banich (2007) found that higher tendency to depressively ruminate is associated with a 
decreased ability to inhibit a previously relevant task set. In contrast, they found that 
when controlling for inhibition, set-switching cost was no longer predictive of 
ruminative tendencies, suggesting that executive dysfunction is more closely linked to 
difficulties in inhibition than to difficulties in switching task sets.  
Zetche, D’Avanzato and Joormann (2012) found that rumination was related to 
having difficulties removing negative information that was no longer relevant from 
working memory. They conclude by suggesting that rumination might be driven by the 
inability to disengage from negative self-reflective thoughts and that high and low 
ruminators differ in the perseverance of rumination, rather than the initiation of these 
thoughts. They further suggest that it is not the immediate ruminating response that is 
maladaptive, but that it may become maladaptive if it persists over time and hinders the 
individual from engaging in activities that could help them recover (Zetche et al., 2012). 
Joormann (2006) also investigated whether differences in ruminative responses relate to 
deficits in inhibition of irrelevant emotional material in working memory. He found that 
those high in rumination also showed impaired inhibition in relation to emotionally 
laden information. 
It has been proposed that a ruminative response to depression will increase the 
effect of negative expectation, and that its negative effect is exercised through making 
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negative cognition more available, specifically the cognitive biases that are related to 
depression (Mor et al., 2014; Nolen-Hoeksema, 1991). One of these biases is the 
interpretation bias, which is assumed to maintain negative emotional states and self-
evaluations and also to enhance a negative memory bias (Mor et al., 2014). Mor and 
associates (2014) found that rumination was associated with an interpretation bias. They 
found that the subjects who had a tendency to ruminate interpreted ambiguous material 
as negative, and especially if this material was related to the content of their ruminative 
thoughts. Another study found associations between trait rumination and negative 
attentional bias in depressed individuals (Donaldson, Lam & Mathews, 2007). 
Rumination has also been related to an over-general style of retrieval of autobiographic 
memories (Park, Goodyer & Teasdale, 2004; Philippot & Brutoux, 2008). For instance, 
one study found that modification of the memory bias and training of dysphoric 
individuals in order to be more specific and less generalizing in their thinking style lead 
to a decrease in depressive symptoms (Watkins, Baeyens & Read, 2009).  
In summary, trait rumination in depressive disorders appears to affect several 
aspects of executive functioning. While some studies demonstrated support for impaired 
mental flexibility (Davis & Nolen-Hoeksema, 2000; Owen & Derakshan, 2013; 
Whitmer & Gotlib, 2012), others find support for impaired inhibition (Watkins & 
Brown, 2002; Whitmer & Banich, 2007). Despite these disagreeing findings, the 
cumulative data on the matter suggests that both trait and state rumination impair 
performance on either inhibition or mental flexibility/switching tasks, or both, across 
clinical and random samples. Other areas of cognitive functioning, including 
interpretation, memory retrieval, and attention are also affected. 
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Background for the Current Study  
As the results from the research presented above suggests, it is assumed that 
deficits in inhibition and mental flexibility may affect the ability to suppress and inhibit 
negative automatic thoughts and switch from ruminative patterns of thinking to new and 
more positive thoughts. This might provide the link between the findings that depressed 
individuals who display a ruminative response style have a greater risk of multiple 
depressive episodes and the findings that depression is characterized by cognitive 
deficits (Joormann & Quinn, 2014). This in the sense that difficulties inhibiting negative 
material that is no longer relevant may provide an explanation as to why depressed 
individuals respond to negative thoughts and moods with recurring and unintentional 
negative cognition. A lot of research has been conducted over the last few years in order 
to gain evidence for this possible link. However, as mentioned previously, there has 
been little research on recurrence in depression. Many people who experience a 
depressive episode once in their lifetime will also experience another episode later on. 
Given the results from research on rumination and deficits in inhibition and mental 
flexibility, it is possible that this will affect the recurrence of depressive episodes. 
However, there have been few studies investigating this relationship. We argue that it is 
important to study the link between performance on tasks on executive functioning and 
self-reported rumination in relation to recurrent depression. This will be of clinical 
relevance, as it will help guide which interventions to choose in treatment of recurrent 
depression, and possibly preventing future depressive episodes. Longitudinal studies 
further give a unique insight into the course of depression as an illness, giving 
information about relapse and recurrence and possible changes in cognitive functioning 
that cross-sectional studies cannot provide. As far as we are aware, there have never 
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previously been studies that investigate the relationship between cognitive functioning 
in first episode major depressive disorder and a five-year follow up on these patients in 
regard to cognitive functioning and rumination.  
The aim of the present study is to investigate the relationship between inhibition 
and trait rumination in a five-year follow up of depressed individuals, who have 
previously been tested at first episode MDD and at one-year follow up.  
We predict that the depressed individuals will perform poorer on measures of 
cognitive inhibition, and therefore still show prevailed cognitive inhibition at T3 (H1).  
We further predict that the depressed individuals will report higher levels of 
rumination compared to the control subjects (H2).  
We predict a correlation between cognitive inhibition and high self-reported 
rumination (H3).  
Finally, we predict that cognitive inhibition will be related to a risk of relapse 
(H4a), that high self-reported rumination will be related to a risk of relapse (H4b) and 
that both these factors will be related to a risk of relapse (H4c).  
Method 
Clinical and Demographic Data 
Patient group (PG). The subjects included in the study were tested at three 
points in time: in the acute phase of illness (T1), one year after inclusion (T2), and five 
years after inclusion (T3). At T1, 30 patients (16 males and 14 females) were included 
in the study, as they met the DSM-IV criteria for a unipolar first-episode MDD 
diagnoses, using the MINI - International Psychiatric Structural Interview (Lecrubier et 
al., 1997). The structural rating scale Montgomery Åsberg Depression Rating Scale 
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(MADRS) (Montgomery & Åsberg, 1979) was administered to measure depression 
severity at all test times.  
  The patients were recruited to the study through cooperation with primary 
physicians and psychologists, who in turn deemed their patient suitable, based on the 
inclusion and exclusion criteria. Inclusion criteria for the patient group were that the 
patient was diagnosed with first-episode MDD, with a minimum score of 20 on 
MADRS, indicating moderate to severe depression. Patients were excluded from the 
study if they reported having experienced former episodes of severe symptoms of 
depression, and if they had been diagnosed with depression and/or had received 
treatment for depression earlier in life. Patients with psychosis, known brain damage, 
severe somatic disorders, alcohol and/or substance abuse, and patients who had been 
treated with electroconvulsive therapy (ECT) were excluded from the study. The 
patients were outpatients receiving either medical treatment (13.3 %), psychological 
treatment (33 %) or both (33.3 %) for the first time, or no treatment at all (23.3 %).  
Control group (CG). A control group (N = 30) was included at T1, with the 
subjects individually matched to the patient group on the basis of gender, age and years 
of education (within a ± 2 year limit). The CG was recruited from the University of 
Bergen and through acquaintances of employees of the Department of Biological and 
Medical Psychology of the University of Bergen. The prospective subjects of the 
control sample were interviewed to survey their history of mental or somatic disorder 
and were excluded if they reported a history of any mental disorder, brain damage 
and/or alcohol or substance abuse.  
All subjects were asked to participate in follow-up assessments. At T2, data 
from two patients are missing due to dropout (N = 28). The mean score on MADRS 
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reported at T2 demonstrated that the patient group had minimal symptoms of 
depression. At T3, ten of the patients were unable to participate in the study (N = 23), 
and the ten individually matched control subjects were therefore not included. Mean 
score on MADRS was showing a normal to mild degree of symptoms of depression in 
the patient group. 
Table 1 
Descriptive data for the patient group and the control group at T1, T2 and T3. 
       Patient Group     Control Group 
 M                          SD M                          SD 
T1 
n 30 30 
Age 26.20                     5.94  26.17                    5.68 
Education 13.97                     1.71 14.03                    1.65  
Males/females 16/14 16/14 
IQ** 118.53                   8.12 120.97                  8.23 
MADRS score 24.77                     3.77  *                           * 
T2 
n 28 28 
Age 26.93                   5.33 26.79                     5.26 
Education 14.29                   1.76 14.68                     1.63 
Males/females 14/14                         15/13                          
IQ** 118.43                 8.40 121.58                   8.18  
MADRS score 9.96                     6.01 *                             * 
T3 
n 23 22 
Age 30.35                     5.74 30.00                    5.98 
Education 15.35                     2.35 16.55                    1.92 
Males/females 11/12 10/12 
IQ** 119.05                   8.45  119.58                   8.48 
MADRS score 8.87                       8.13 *                           *  
* Control group, no history of illness. 
** IQ measured at inclusion, T1. 
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Patient subgroups (PSG). At T2 the patient group was interview regarding the 
course of their symptoms, and further categorized into different subgroups based on this 
retrospective interview (Table 2). This categorization resulted in a relapse group (RG) 
(N = 11), a no-relapse group (NRG) (N = 5), and a third no-change group (NCG) (N = 
5), that experienced little change in symptomology since inclusion. The NCG reported a 
mean MADRS score of 18, indicating mild to moderate depression requiring treatment. 
The RLG and NRG reported a MADRS mean of < 10, showing low depression severity. 
At T3, a psychologist re-interviewed the PG. Thirteen subjects were categorized 
into the Relapse Group (N = 17) and five of the subjects were placed in the no-relapse 
group (N = 6). None of the subjects in the patient group reported no change since T2 (N 
= 0). MADRS score was reported to be < 10, showing a normal to moderate depression 
severity also at this point in time.  
Relapse was defined as the subject returning to a fully symptomatic state of 
depression after a minimum three-week period with none or minimal levels of 
symptoms (Frank et al., 1991, as cited in Schmid & Hammar, 2013a). To fulfill the 
criteria of relapse, the subject had to report the relapse period as having lasted a 
minimum of two weeks. In the present study, difficulties performing at an optimal level 
in areas such as school, work or socials setting, was added to the definition of relapse.  
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Table 2 
Descriptive data for the relapse group (RLG), the no-relapse group (NRG), the no change group (NCG) and the control group 
(CG) at T1, T2 and T3. 
 RLG NRG NCG CG 
 M                            SD   M                        SD   M                         SD  M                         SD 
T1 
n  11   12   5  30 
Age 25.09                   6.47  25.25                   4.09  29.60                   4.88  26.17                5.68 
Education 14.27                   1.62  14.25                   1.96  13.00                   1.41  14.03                1.65 
Males/females 3/8  10/2  1/4  16/14 
IQ** 115.46                6.53  119.08                9.65  123.40                 7.57  120.97              8.23 
MADRS score 24.55                   4.39  23.83                   3.01  28.00                   3.16  *                         * 
T2 
n  11  12   5   28 
Age 26.00                   6.43  26.25                   4.00  30.60                   4.88  26.96                5.26 
Education 14.64                   1.69  14.42                   1.93  13.20                   1.30  14.68                1.63 
Males/females 3/8  10/2  1/4  15/13 
IQ** 115.46                6.53  119.03                 9.65  123.40                 7.57  120.97             8.23 
MADRS score 9.09                     5.19  7.42                      3.53  18                         6.33  *                         * 
T3 
n  17   6  0  22 
Age 28.88                  4.50  34.50                   7.23  *                             *  30.00                6.32 
Education 15.06                  2.41   16.17                   2.14  *                             *  16.55                1.92 
Males/females 7/10  4/2  *                             *  10/12 
IQ** 118.00                8.49  121.83                 8.42  *                             *  119.58             8.48 
MADRS score 10.88                  8.42  3.17                     3.43  *                             *  *                         * 
Number of relapse 2.27                    3.25  .00                        .00  *                             *  *                         * 
* Control group, no history of illness  
** IQ measured at inclusion, T1. 
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Procedure and Neuropsychological Assessment  
The neuropsychological assessment was conducted at the Institute of Biological 
and Medical Psychology, University of Bergen, Norway. A trained senior test 
technician administered the testing. The test technician was not blinded to group 
membership for the patient and control subjects due to recruitment procedures. The 
neuropsychological tests were given to all patients in the same sequence. The tests were 
part of a larger test battery (the Delis-Kaplan Executive Function System), including IQ 
measurements (WASI) and other standardized and experimental tests. The procedure 
and tests used was the same at all test times. 
D-KEFS Color-Word Interference Test (CWIT). The CWIT is a modified 
version of the Stroop procedure from 1935, and is meant to measure the subject’s ability 
to inhibit an overlearned verbal response and comprises four conditions (Stroop, 1935). 
Condition 1: Color naming (C), condition 2: Word Reading (W), condition 3: Inhibition 
(CW) and condition 4: Inhibition/switching (IS). Conditions 1 and 2 are baseline 
conditions measuring key component skills of higher-level tasks, by naming color 
patches and reading color-words printed in black ink. Errors commited on one or both 
of these conditions could be related to fundamental skills, and/or perseverative 
tendencies. Errors in the latter occur when the subject is unable to inhibit the production 
of a previous response. Condition 3 is the traditional Stroop task, where the subjects 
must inhibit reading the words in order to name the dissonant ink color that the word is 
printed in. In condition 4 the subject is asked to switch back and forth between naming 
the dissonant ink colors and reading the words. This condition is meant to measure both 
inhibition and cognitive flexibility, as performance on this task requires adequate 
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naming speed, reading speed, verbal inhibition and cognitive flexibility. For further 
reference, Cognitive inhibition is often used as a collective term for the CWIT. 
Rating Scales on Depression and Rumination 
Montgomery Åsberg Depression Rating Scale (MADRS). The MADRS is a 
depression rating scale developed by Montgomery and Åsberg (1979). The MADRS is a 
rather short rating scale that is meant to be easily applied in clinical settings. All items 
included in the scale are related to core symptoms of depressive illness, and the scale is 
highly sensitive to change in severity of depressive symptoms. It consists of 10 items, 
where item 1 is based on the clinician’s observation of the patient, whether he or she 
looks visibly sad or depressed. All items are rated on a scale from 0 (normal) to 6 (deep 
symptom severity), where 60 is the highest score possible to obtain.   
Ruminative Response Scale (RRS). The RRS (Treynor, Gonzales & Nolen-
Hoeksema, 2003) is the most commonly used measurement investigating rumination in 
depression. It is part of the Response Styles Questionnaire (RSQ), which is designed to 
screen for common responses to depressed mood. The RRS consists of 24 items, which 
upon analysis have been found to separate into two subsets of factors, namely brooding 
and reflection (Schoofs, Hermans & Raes, 2010). In the present study, the full-scale 
RRS has been used without separating between brooding and reflection. Each item is 
rated on a Likert scale from 1-4, where 1 is almost never, and 4 is almost always.  
Rumination-Reflection Questionnaire (RRQ). The RRQ was developed by 
Trapnell and Campbell (1999) and is intended to separately measure anxious self-
reflection and curious introspection. Trapnell and Campbell (1999) define reflection as a 
“self-attentiveness motivated by curiosity or epistemic interest in the self” (p. 297), 
while rumination is construed as “self-attentiveness motivated by perceived threats, 
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losses, or injustices to the self” (p. 297). Rumination and reflection appear to be 
essentially independent tendencies, as the correlation between these two factors was 
minimal (Trapnell & Campbell, 1999). The RRQ consists of 24 items, or statements, 
concerning rumination and reflection. The participants are asked to report how much 
they agree with each statement, using a scale from 1 to 5, where 1 represents strongly 
disagree, and 5 represents strongly agree. Items 1 to 12 are statements describing 
ruminative tendencies, while 13 to 24 hold reflective values. In the present study, only 
questions 1-12 have been included in the analysis as a specific measurement on 
rumination.  
Descriptive data for the patient group and control group on the RRS and RRQ 
are presented in Table 3. 
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Table 3 
Descriptive data for the patient group and control group on the RRS and RRQ. 
    Patient Group   Control group 
 M                  SD M                 SD 
T1 
n RRS 14 0 
RRS total score 58.07            10.85 *                    * 
n RRQ 6 25 
RRQ-rumination score 46.00            5.62 33.72             6.55 
T2 
n RRS 27 0 
RRS total score 45.15            11.95 *                    *  
n RRQ 25 28 
RRQ-rumination score 44.76            8.58 30.54             6.98 
T3 
n RRS 23 22 
RRS total score 48.43            13.31 30.77             8.02 
n RRQ 23 22 
RRQ-rumination score 48.43            12.57 32.41              9.50 
* No subjects in the control group filled out the RRS at T1 and T2. 
Informed consent was obtained from all participants at T1. The study was 
performed in accordance with the Helsinki Declaration of the World Medical 
Association Assembly. The Regional Committee for Medical Research Ethics and The 
Norwegian Data Protection Authority approved this study.  
Results 
Data Scoring and Analysis 
 Statistical analysis of the data was conducted using the Statistical Package for 
the Social Sciences (SPSS) version 23.0. An alpha level of < .05 was used for the 
statistical tests comparing the patient and control groups. To avoid making a type II 
error, we redid the analysis conducted on the PSG, using an alpha level of < .10. There 
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were no changes in the significant findings, thus all the following results are presented 
with an alpha level of < .05. The data was checked for outliers using boxplots. No 
outliers were removed however, as they were judged to be of clinical value. The data 
analyses were conducted in two main parts. First, preliminary analysis between the 
patient group and the control group was conducted to explore whether they matched on 
demographic variables and whether they differed on CWIT from T1 to T3. Secondly, 
the analysis concerning whether the control group and the patient group differed on 
performance on CWIT and responses on RRS and RRQ at T3 were conducted. Then, 
the analysis concerning the PSG were conducted, as well as the analysis concerning a 
possible relationship between rumination and performance on CWIT for the patient 
group, using the subgroups, and the control group. Finally, analysis of regression was 
performed to investigate the predictive value of the RRS/RRQ and CWIT.   
Preliminary Analysis 
 Independent samples t-tests were computed to check whether the control group 
and the patient group matched on the demographic variables age, education and IQ at 
T1 and T3 separately. An independent sample t-test was also used to check whether the 
PSG differed in MADRS score at T1 and T3. Chi-square was used to check whether the 
control group and the patient group matched in gender. The results showed no 
significant differences on group means on the different variables, or in distribution of 
gender. One-way analysis of variance (ANOVA) was conducted at T1 and T3 to 
compare the relapse group, the no-relapse group, the no-change group and the control 
group on the mentioned demographic variables. No differences in means were found, 
except from a mean difference in MADRS score at T3 for the PSG, F (1,21) = 4.69, p = 
.04. Post-hoc comparisons, using Tukey HSD test, show a significant difference in 
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education between the RLG (M = 13.5, SD = 1.6) and the NRG (M = 15.5, SD = 1.2) at 
T1. 
To investigate whether the control group and the patient group differed in 
performance on CWIT from T1 to T3, a mixed between-within repeated measures 
ANOVA was conducted. The basic design was Group (patient and control group) x Test 
occasion (T1 and T3) x Test condition (C, W, CW and IS). CWIT was measured by the 
number of seconds each subject required to complete the trial, and the data used was the 
raw scores. Assumptions of equality of variances were met, but Box’s test of equality of 
covariance matrices was significant and one must therefore be careful when interpreting 
the results. The main effect of group was significant, F (1, 39) = 15.20, p = .000, partial 
eta squared = .280, suggesting there is a difference in performance between the patient 
and control group. The results are presented in Table 5. 
To further investigate the difference between the control group and the patient 
group on the CWIT, a collective mean score for condition 1 and 2, and a collective 
mean score for condition 3 and 4 was computed. The mean score for condition 1 and 2 
represents lower cognitive functioning, while the mean score for condition 3 and 4 
represents higher cognitive functioning. Mean differences between the patient group 
and the control group on the Higher and Lower Cognition scores are shown in Figure 1. 
A mixed between-within repeated measures ANOVA was conducted using the two 
mean scores. The basic design was Group (patient and control group) x Test occasion 
(T1 and T3) x Test condition (Lower and Higher Cognition score). Assumptions of 
equality of variances were met, but Box’s test of equality of covariance was significant. 
One must therefore be careful when interpreting the results. The main effect comparing 
the group difference was significant, F (1, 39) = 14.49, p = .000, partial eta squared = 
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.271, suggesting there is a difference in performance between the patient and control 
group. The results are presented in Table 5.  
 
Figure 1  
Mean scores and significant difference between patient group and control group on the Higher and Lower 
Cognition scores at T3. 
* Significant on a < .05 level. 
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Table 5  
Cognitive performance in the PG and CG across T1 and T3 
                                       Main Effect Interaction Effect 
   
Condition 
 
Time 
 
Time x 
Group 
 
Time x 
Condition 
 
Group x 
Condition 
Time x 
Condition x 
Group 
  
Wilks λ 
 
0.038 
 
0.675 
 
0.962 
 
0.792 
 
0.885 
 
0.943 
CWIT   
F (df) 
 
309.60 (3,37) 
 
18.81 (1,39) 
 
1.54 (1,39) 
 
3.24 (3,37) 
 
1.60 (3,37) 
 
0.75 (3,37) 
  
Eta sq. 
 
0.962 
 
0.325 
 
0.038 
 
0.208 
 
0.115 
 
0.057 
  
F-sig 
 
p = .000* 
 
p = .000* 
 
p = .222 
 
p = .033* 
 
p = .205 
 
p = .531 
 
  
Wilks λ 
 
0.057 
 
0.667 
 
0.978 
 
0.812 
 
0.894 
 
0.992 
Lower/ 
Higher 
 
F (df) 
 
644.09 (1,39) 
 
19.49 (1,39) 
 
0.89 (1,39) 
 
9.02 (1,39) 
 
4.63 (1,39) 
 
0.30 (1,39) 
  
Eta sq. 
 
0.943 
 
0.333 
 
0.022 
 
0.118 
 
0.106 
 
0.008 
  
F-sig 
 
p = .000* 
 
p = .000* 
 
p = .351 
 
p = .005* 
 
p = .038* 
 
p = .583 
* Significant on a < .05 level.  
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Bivariate correlation was used to explore the relationship between depression 
severity, measured by MADRS, and the CW and IS raw scores, contrast scores and the 
Higher Cognition score, and between depression severity and rumination, measured by 
RRS sum score and RRQ rumination, on T3. Results are shown in Table 6. 
Table 6  
Correlation coefficients between depression severity, inhibition and rumination at T3 
 
 Inhibition  Inhibition/ 
Switching 
Higher 
Cognition 
CW 
Contrast 
IS 
Contrast 
RRS RRQ 
 
MADRS 
r = .122 
n = 23 
p = .581 
r = .518* 
n = 23 
p = .011 
r = .210 
n = 23 
p = .336 
r = -.103 
n = 23 
p = .639 
r = .395 
n = 23 
p = .062 
r = .496* 
n = 23 
p = .016 
r =.253 
n = 23 
p = .245 
* Correlation is significant on a < .05 level (2-tailed) 
Main Analysis 
CWIT. A multivariate ANOVA was conducted in order to investigate the mean 
differences on the four conditions on CWIT between the control group and the patient 
group at T3. The independent variable was group, with two levels. The dependent 
variables were the four different conditions on CWIT. Box’s test of equality of 
covariance matrices was significant, and one must therefore be careful when 
interpreting the results. The results show a significant difference between the two 
groups, F (4,40) = 5.44, p = .001, Wilk’s Lambda = .648, partial eta squared = .352. The 
between-subjects effects results are shown in Table 7.  
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Table 7 
Between-Subjects Effects - Patient Group and Control Group on CWIT 
 Condition 
 
 
CWIT 
 Color Naming Word Reading Inhibition Inhibition/ 
Switching 
F (df) 9.28 (1,43) 19.44 (1,43) 11.96 (1,43) 9.89 (1,43) 
Eta sq. 0.178 0.311 0.218 0.187 
F-sig.  p = .004* p = .000* p = .001* p = .003* 
* Significant on a < .05 level 
A multivariate ANOVA was also computed to investigate the mean differences 
between the Higher and Lower Cognition scores between the patient group and the 
control group. The independent variable was group, with two levels, and the dependent 
variables were the two combination scores. Assumptions of equality of variance were 
met. The results show a significant difference between the groups, F (2,42) = 8.73, p = 
.001, Wilk’s Lambda = .706, partial eta squared = .294. The between-subjects effects 
show a significant difference between the groups on the Higher Cognition variable, F 
(1,43) = 15.66, p = .000, partial eta squared = .267, and on the Lower Cognition 
variable, F (1,43) = 12.12, p = .001, partial eta squared = .220.  
Rumination. A multivariate ANOVA was conducted to investigate the mean 
differences between the patient group and the control group on the two measures on 
rumination, RRS and RRQ, at T3. The independent variable was group, using two 
levels: patient group and control group. The dependent variables were RRS sum scores 
and RRQ rumination sum scores at T3. Assumptions of equality of variance were met. 
The results show a significant difference between the two groups, F (2,42) = 13.65, p = 
.000, Wilk’s Lambda = .650, partial eta squared = .394. The between-subjects effects 
show a significant difference between the groups on RRS, F (1,43) = 26.03, p = .000, 
partial eta squared = .377, and between the groups on RRQ, F (1,43) = 9.29, p = .004, 
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partial eta squared = .178. When inspecting the mean scores for the PG and the CG for 
both RRS and RRQ, the patient group displays higher mean scores for both measures, 
although the difference is greater for RRQ.  
Patient subgroups. A multivariate ANOVA was computed in order to 
investigate mean differences between the patient subgroups (RLG and NRG) and the 
control group on the four conditions on CWIT at T3. The independent variable was 
group, with three levels, and the dependent variables were the four conditions on CWIT. 
Assumptions of equality of variances were met. The results show a significant 
difference between the groups, F (8,78) = 2.63, p = .013, Wilk’s Lambda = .620, partial 
eta squared = .212. The between-subjects effects results are shown in Table 8. Results 
from post-hoc comparisons, using the Tukey HSD test, are shown in Figure 2.  
Table 8  
Between-Subjects Effects - Relapse Group, No-relapse Group and Control Group on CWIT 
 Condition 
 
 
CWIT 
 Color Naming Word Reading Inhibition Inhibition/ 
Switching 
F (df) 4.57 (2,42) 9.51 (2,43) 5.97 (2,43) 5.20 (2,43) 
Eta sq. 0.179 0.312 0.221 0.199 
F-sig.  p = .016* p = .000* p = .005* p = .01* 
* Significant on a < .05 level 
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Figure 2  
Mean Scores and Tukey HSD Significance Between RLG, NRG and CG on CWIT 
* Significant difference between the RLG and the CG on a < .05 level 
** Significant difference between the RLG and CG and between NRG and CG on a < .05 level 
A multivariate ANOVA was also computed to investigate the mean group 
differences between the patient subgroups (RLG and NRG) and the control group on 
rumination, measured by sum scores on RRS and on RRQ rumination at T3. The 
independent variable was group, with three levels (RLG, NRG and CG), and the 
dependent variables were RSS sum score and RRQ rumination sum score. Assumptions 
of equality of variance were met. The results show a significant difference between the 
groups, F (4,82) = 8.39, p = .000, Wilk’s Lambda = .291, partial eta squared = .291. The 
between-subjects effects show a significant difference between the three groups on 
RRS, F (2,42) = 18.78, p = .000, partial eta squared = .472, and on RRQ, F (2,42) = 
8.97, p = .001, partial eta squared = .299. Results from post-hoc comparisons, using the 
Tukey HSD test, show a significant difference between the RLG (M = 52.1, SD = 10.9) 
and the NRG (M = 38, SD = 14.8) and between the RLG and the CG (M = 30.8, SD = 
9.5) for RRS. For RRQ, post-hoc comparisons show a significant difference between 
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the RLG (M = 45.4, SD = 10) and the NRG (M = 32.7, SD = 15.3) and between the 
RLG and the CG (M = 32.4, SD = 8). Results are displayed in Figure 3.  
 
Figure 3  
Mean Sum Scores and Tukey HSD Significance between the RLG, NRG and CG on RRS and RRQ 
* Significant difference between RLG and NRG and between RLG and CG on < .05 level 
A one-way between-groups ANOVA was computed to explore the mean group 
differences between the patient subgroups (RLG and NRG) and the control group on 
RRS at T3. Assumptions of equality of variances were met. The results show a 
statistical significance between the three groups, F (2,42) = 18.78, p = .000. The effect 
size was calculated using eta squared, and showed a large effect size, .472. Post-hoc 
comparisons using the Tukey HSD test show that the mean score for the RLG (M = 
52.12, SD = 10.92) was significantly different from the NRG (M = 38, SD = 14.89), p = 
.023, and the CG (M = 30.77, SD = 9.50), p = .000. The NRG did not differ significantly 
from the CG.  
A one-way between-groups ANOVA was also computed between the RLG, the 
NRG and the CG on RRQ at T3. Assumptions of equality of variances were met. The 
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results here show a statistical significant difference between the three groups, F (2,42) = 
8.97, p = .001. Effect size was calculated using eta squared, .299, which is a large effect 
size, though smaller than what was found for RRS. Post-hoc comparisons using the 
Tukey HSD test show that the mean score for the RLG (M = 45.35, SD = 9.99) was 
significantly different from the NRG (M = 32.67, SD = 15.267) p = .026, and the CG (M 
=32.41, SD = 8.02), p = .001. The NRG did not significantly differ from the CG.  
Correlation Analysis. Correlation analyses were performed using Pearson’s R, 
in order to explore the relationship between the CW and IS conditions on CWIT and 
RRS sum scores on T3 and between the CW and IS conditions and RRQ rumination at 
T3. The analyses were conducted for all subjects, and for the control group and the 
patient group. Further, the analyses were also conducted for the patient subgroups (RLG 
and NRG). Correlation coefficients were further computed for the contrast scores and 
the Higher and Lower Cognition scores for all groups Results are shown in Tables 9 and 
10.  
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Table 9  
Correlation Coefficients (Pearson’s R) between RRS, RRQ and CWIT at T3 
  Inhibition Inhibition/Switching Lower Cognition 
Higher 
Cognition 
CW 
Interference 
Score 
IS 
Interference 
Score 
RRQ 
All Subjects (n 
= 45) 
 
RRS 
 
.305* 
 
.361* 
 
.412** 
 
.368* 
 
.137 
 
 
.242 
 
 
.811** 
         
PG (n = 23) RRS .124 .386 .376 .315 -.045 .280 .817** 
         
CG (n = 22) RRS -.180 -.158 -.230 -.268 -.055 -.089 .668** 
         
RLG (n = 17) RRS -.152 .202 .123 .086 -.237 .190 .654** 
         
NRG (n = 6) RRS .868* .571 .886* .791 .784 .209 .943** 
* Correlation is significant at a < .05 level (2-tailed) 
** Correlation is significant at a < .01 level (2-tailed) 
Table 10 
Correlation Coefficients (Pearson’s R) between RRQ and CWIT at T3 
 
 
Inhibition 
 
Inhibition/Switching 
 
Lower 
Cognition 
 
Higher 
Cognition 
 
CW 
Interference 
Score 
 
IS 
Interference 
Score 
All Subjects (n 
= 45) 
 
RRQ 
 
.293 
 
.306* 
 
.282 
 
.302* 
 
.205 
 
.243 
        
PG (n = 23) RRQ .293 .345 .235 .336 .251 .314 
        
CG (n = 22) RRQ - .282 - .091 - .185 - .307 - .193 -.029 
        
RLG (n = 17) RRQ .042 .063 - .218 .056 .151 .221 
        
NRG (n = 6) RRQ .970** .629 .922** .879* .938** .266 
* Correlation is significant at a < .05 level (2-tailed) 
** Correlation is significant at a < .01 level (2-tailed) 
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Logistic Regression. A direct logistic regression was performed to explore the 
impact of poor performance on CWIT on the likelihood of experiencing relapse at T3 in 
the patient group. The full model containing the predictor (Higher Cognition at T2) was 
not significant χ2 (1, N=21) = 0.95, p = .330. This indicates that the model is not able to 
distinguish between those who relapsed at T3 and those who did not. The model as a 
whole explained between 4.4 % (Cox and Snell R Squared) and 6.3 % (Nagelkerke R 
Squared) of the variance and correctly classified 76.2 % of the cases. None of the 
variables contributed significantly to the model (Table 12) 
Table 12  
Logistic Regression Predicting Likelihood of Relapse at T3 from Higher Cognition 
  
B 
 
S.E. 
 
Wald 
 
df 
 
p 
Odds 
Ratio 
95.0 % C.I. for 
Odds Ratio 
       Lower Upper 
Higher 
Cognition 
- .047 .050 0.903 1 .342 0.954 .866 1.051 
Constant 3.368 1.622 1.622 1 .203 29.011   
A direct logistic regression was performed to explore the impact of a tendency to 
ruminate on the likelihood of experiencing relapse at T3 in the patient group. The full 
model containing the predictors (RRQ rumination sum score and RRS sum score at T2) 
was not significant χ2 (2, N=19) = 1.86, p = .394. This indicates that the model is not able 
to distinguish between those who relapsed at T3 and those who did not. The model as a 
whole explained between 9.3 % (Cox and Snell R Squared) and 13.1 % (Nagelkerke R 
Squared) of the variance and correctly classified 63.2 % of the cases. None of the 
variables contributed significantly to the model (Table 13). 
 
 
INHIBITION AND RUMINATION IN DEPRESSION     40	  
Table 13 
Logistic Regression Predicting Likelihood of Relapse at T3 from RRS and RRQ 
  
B 
 
S.E. 
 
Wald 
 
df 
 
p 
Odds 
Ratio 
95.0 % C.I. for Odds 
Ratio 
       Lower Upper 
RRS .037 .060 .383 1 .536 1.038 .923 1.167 
RRQ .037 .074 .245 1 .620 1.037 .897 1.200 
Constant -2.487 2.610 .908 1 .341 0.083   
A direct logistic regression was performed to explore the impact of poor 
performance on CWIT and a tendency to ruminate on the likelihood of experiencing 
relapse at T3 in the patient group. The full model containing the predictors (Higher 
Cognition at T2, RRQ rumination sum score and RRS sum score at T2) was not 
significant χ2 (3, N=19) = 3.91, p = .271. This indicates that the model is not able to 
distinguish between those who relapsed at T3 and those who did not. The model as a 
whole explained between 18.6 % (Cox and Snell R Squared) and 26.1 % (Nagelkerke R 
Squared) of the variance and correctly classified 73.7 % of the cases. None of the 
variables contributed significantly to the model (Table 14). 
Table 14 
Logistic Regression Predicting Likelihood of Relapse at T3 from Higher Cognition, RRS and RRQ 
  
B 
 
S.E. 
 
Wald 
 
df 
 
p 
Odds 
Ratio 
95.0 % C.I. for 
Odds Ratio 
       Lower Upper 
RRS .039 .068 .333 1 .564 1.040 .911 1.187 
RRQ .076 .087 .761 1 .383 1.079 .910 1.279 
Higher 
Cognition 
- .082 .060 1.890 1 .169 0.921 .819 1.036 
Constant .082 3.164 .001 1 .979 1.085   
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Discussion 
The results in the present study show that the hypothesis regarding poorer 
performance on measures of cognitive inhibition in the patient group, compared to the 
control group, was supported. The second hypothesis, regarding self-reported higher 
levels of rumination in the patient group compared to healthy controls was also 
supported. The results further show that the hypothesis regarding a positive correlation 
between cognitive inhibition and self-reported rumination was also supported. The 
hypotheses concerning the relationship between cognitive inhibition, rumination and a 
risk of relapse at T3 were, however, not supported. The results will be discussed in the 
following sections, along with discussions on methodological considerations and 
clinical implications.  
 Preliminary analyses show that the patient group and control group matched on 
demographic variables. The only exception was a difference in depression severity for 
the patient subgroups, but this was expected, as the no-relapse group has not 
experienced any depressive episodes since T2, in contrast to the relapse group.  
Correlation analysis between depression severity and performance on Cognitive 
Inhibition and self-reported rumination show statistically significant positive 
correlations between MADRS and the condition four on CWIT, which might indicate 
that the performance on this task is confounded by the severity of the depressive 
symptoms in the patient group. There was further a statistically significant correlation 
between MADRS and RRS sum score. This correlation will be further discussed in the 
strengths and limitations section. 
The preliminary analysis further shows that the patient group and control group 
differ significantly in performance on CWIT across time, which is in concurrence with 
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the findings from T1 and T2 (Schmid & Hammar, 2013b). When using the combination 
scores, we found the same results, suggesting that difference in performance is not due 
to poorer cognitive processing speed alone for the patient group. According to the D-
KEFS examiners manual (Delis, Kaplan, & Kramer, 2001), one can separate between 
higher and lower cognitive functions on the CWIT, where the color naming and word 
reading conditions are considered to be lower mental functions that are automatic and 
do not require higher-level processes. The sum of the two first conditions of CWIT, the 
average of which comprise the Lower Cognition variable, has been conceptualized as a 
composite score of basic cognitive functioning (Lippa & Davis, 2010). On the other 
hand, conditions 3 and 4 are considered to be higher cognitive tasks, which rely on more 
sophisticated processes (Lippa & Davis, 2010). The patient group and the control group 
differed significantly on mean Higher Cognition combination scores and on mean 
Lower Cognition combination scores.  
 In order to test the first hypothesis, the difference between the patient group and 
the control group, as well as the patient subgroups, on the performance of the CWIT, 
and level of rumination at T3 alone was investigated. Based on former research, it was 
expected that the patient group would perform significantly poorer than the control 
group on the conditions 3 and 4 on the CWIT. It was further expected that the relapse 
group would have significantly longer response times than the no-relapse group. The 
results support the hypothesis and showed that the patient and control group differed 
significantly on the performance in all conditions. The results also demonstrated a 
significant difference between the groups on the Lower Cognition variable and the 
Higher Cognition variable. These findings are consistent with the findings of Schmid 
and Hammar (2013a, 2013b) from T1 and T2, which demonstrated that the patient 
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group performed significantly poorer on condition 4 when analyzing the raw scores on 
the CWIT.  
When investigating the patient subgroups and control group on the four 
conditions of the CWIT, there was a significant difference between the groups. The 
post-hoc test demonstrated that the relapse group performed significantly poorer than 
the control group on all four conditions, while the no-relapse group performed 
significantly poorer than the control group on condition 2 and condition 4. There were 
no significant differences between the relapse group and the no-relapse group on any of 
the four CWIT conditions. Schmid and Hammar (2013b) reported a tendency for those 
patients who experienced relapse within the first year after initial episode to perform 
poorer on conditions 3 and 4 tested at T2, compared to the no-relapse group and the 
control group. It was not possible to fully replicate these findings at T3, as there was no 
significant difference between the relapse group and the no-relapse group. Research has 
demonstrated that both depressed and remitted patients struggle with moderate deficits 
on attention and executive functioning tasks (Rock et al., 2014), and since the relapse-
group has experienced one or more depressive episode between T2 and T3, we expected 
the group to perform poorer than the no-relapse group.  
In summary, when testing the first hypothesis, it was supported that the patient 
and control groups differ on measures of Cognitive Inhibition. This holds true both for 
the patients who had relapsed and for those who had experienced no new episodes of 
depression since T2. There was no difference in impairment of Cogntive Inhibition 
between the two patient subgroups. 
 In the second hypothesis, it was expected that the patient group would report 
higher levels of self-reported rumination than the control group. In relation to this, it 
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was further expected that the patients who experienced relapse since T2 would ruminate 
more than the patients who did not. The results demonstrated a significant difference 
between the patient group and the control group on scores on the RRS and the RRQ at 
T3 respectively. This indicates that the patient group reported significantly higher levels 
of rumination than the control group, on both questionnaires. This was expected, as trait 
rumination seems to be a quite stable tendency that is consistent over time and across 
levels of depressive symptoms (Nolen-Hoeksema & Davis, 1999; Nolen-Hoeksema et 
al., 2008). The patients who experienced relapse since T2 scored significantly higher 
than the no-relapse group and the control group on both RRS and RRQ. This is 
consistent with previous findings indicating that a ruminative response style has been a 
predictor of relapse risk in individuals who experience depressive mood (Huffziger et 
al., 2009; Michalak et al., 2011; Nolen-Hoeksema, 2000). These findings will be 
discussed later in the paper. There was no significant difference between the no-relapse 
group and the control group in rumination means scores. The no-relapse group reported 
a slightly higher mean score than the control group on the RRS, but not on RRQ 
rumination. One would expect that the no-relapse group would show higher levels of 
rumination than the control group, but this is not the case in the present study. Generally 
in our findings, the RRS has been more effective in reporting differences between 
groups, and this might explain the slight difference in mean score. RRQ is a more 
concentrated rumination questionnaire than RRS, and when investigating RRQ there 
was no difference between the control group and the no-relapse group. This will be 
further discussed later on.  
 Thus, the findings when testing the second hypothesis indicate that there is a 
difference between healthy controls and previously depressed individuals in their 
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tendency to ruminate. In addition, it seems that the patients who have relapsed since T2 
ruminate more than those who have remained symptom-free, a finding that is in keeping 
with other research on the subject.  
Correlation analysis was performed in order to test the third hypothesis. When 
looking at the correlations between RRS/RRQ and CWIT, results showed the strongest 
relationships when the analyses for all the subjects were performed. Across the patient 
and control groups, there was a significant correlation between RRS and CWIT 
conditions 3 and 4, and the Higher and Lower Cognition variables respectively. RRQ 
was significantly correlated with CWIT condition 4 and Higher Cognition. This is in 
accordance with the hypothesis. It was not part of the hypotheses that lower cognitive 
functions would correlate with rumination, and it is therefore interesting that this was 
the case with the RRS. It is worth to note, however, that the Lower Cognition variable 
was not significantly correlated with the RRQ. The correlations with CWIT condition 3 
and 4 and Higher Cognition were expected, as these conditions require more effort and 
cognitive control, which is hypothesized to be related to rumination. That a higher score 
on the rumination measures is associated with a slower response on the more 
demanding Cognitive Inhibition tasks, indicates that people who tend to ruminate have 
impaired cognitive inhibition, which is in keeping with the hypothesis. 
When separating between the patient and control groups, the strength of the 
above-mentioned correlations diminished and did not reach statistical significance. 
Further, looking at the relapse group and no-relapse group separately, there were no 
significant correlations between RRS/RRQ and inhibition in the relapse group. In the 
no-relapse group, however, both RRS and RRQ were significantly correlated with the 
Lower Cognition variable and condition 3 of CWIT. Thus, there is a stronger 
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relationship between Cognitive Inhibition and rumination for the previously depressed 
who have not relapsed, than for those who have had subsequent episodes since T2. It 
was not predicted that there would be a relationship between basic cognition and 
rumination, as was found in the no-relapse group. It was expected that the association 
between inhibition and rumination would be just as strong or stronger in the relapse 
group as in the no-relapse group, but the results did not support this.  
Results showed a significant association between the RRS and RRQ-rumination 
scales across all subjects and subgroups in the study. Hence, the two questionnaires 
evoke a similar pattern of responses, which will be discussed later. 
In summary, the measures of rumination used in this study have displayed a 
significant correlation with Cognitive Inhibition as measured by CWIT for all subjects 
included in the study. There was not found any significant correlations between 
Cognitive Inhibition and measures of rumination in previously depressed patients who 
have relapsed since their first depressive episode. On the measures used, there is no 
difference between the patient and control groups in the strength of the relationship 
between inhibition and rumination.  
As mentioned earlier, there was no support for the hypotheses that poor 
performance on CWIT and high self-reported rumination would be able to predict who 
would experience relapse between T2 and T3. The model was able to correctly classify 
73.7 percent of the cases, even though none of the variables of interest contributed in a 
statistically significant way. The predictive models for both RRS/RRQ and Higher 
Cognition separately were also not significant. Methodological consideration will be 
discussed in further detail later on, but it is important to note that the low n in the no-
relapse group might affect the results here. To the extent of our knowledge, this is the 
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first longitudinal study investigating the relationship between impaired cognitive 
inhibition, rumination and a risk of relapse in clinically depressed patients. There is also 
a possibility that different results might be seen at the ten-year follow-up, but this is 
difficult to say at this point. At T2, logistic regression analysis did show that poor 
performance on condition 3 and 4 on CWIT, using contrast scores, was related to a risk 
of relapse (Schmid & Hammar, 2013a), and that it was condition 4 that contributed 
significantly to the model. It therefore seems that this predictive value is no longer 
relevant at the five-year follow-up, as we were not able to obtain similar results. 
However, it is important to note that rumination was not included in the analysis at T2, 
which might affect the results, even though none of the variables contributed 
significantly. It was the RRS and RRQ scores that had the highest Odd’s Ratio (1.040 
and 1.079), which might further indicate that the Higher Cognition factor (OR 0.921) no 
longer is as related to risk of relapse as it was at T2. 
Previous longitudinal studies investigating the cognitive impairments in former 
depressed individuals have found differing results. There seems to be a general 
consensus that patients in the acute phase of a depressive disorder show cognitive 
impairments in different domains, like memory, executive functioning and attention 
(Hammar & Årdal, 2009). Douglas and Porter (2009) concluded in their review that 
executive functioning remains impaired over time. It is worth to note that the studies 
used in this review focused on relatively short periods of time, with most of them being 
≤ 6 months. A meta-analysis and systematic review by Rock and colleagues (2014) 
showed that patients continue to show impaired cognitive abilities, specifically in the 
domain of executive functioning, when in a state of remission. However, this study was 
not conducted in order to investigate differences over time, but to investigate the 
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difference between patients who are currently depressed and patients in a state of 
remission (Rock et al., 2014). A two-year follow-up study by Biringer and associates 
(2005) found that patients who had recovered completely from a depressive episode 
also showed a recovery on executive functions, compared to healthy controls, however 
the results showed prevailed impairment in measures of cognitive inhibition. A study by 
Hammar and Årdal (2012) found no continuous impairment in effortful information 
processing at a ten-year follow-up of depressed patients. Another study by Årdal and 
Hammar (2011) found that at the ten-year follow-up the depressed patients show 
impairments in inhibition that was associated with the impairments shown at inclusion. 
Previous depressive episodes was not an exclusion criterion in this study, and they did 
not include rumination as a factor of interest (Årdal & Hammar, 2011). These results 
are of relevance to the current study, as it shows that impairments in inhibition are 
persistent over the course of ten years. It appears that it is difficult to conclude whether 
or not people suffering from recurrent depression will continue to show impairments in 
executive functioning over time (Hammar & Årdal, 2009). Reviews show that patients 
appear to continue to show impaired executive functioning (Douglas & Porter, 2009; 
Rock et. al, 2014), but few longitudinal studies that span across several years have been 
conducted (Hammar & Årdal, 2009).  
As mentioned previously, studies have linked rumination to both an increase in 
number and severity in depressive symptoms over time (Nolen-Hoeksema, 2000), and 
there is emerging evidence that rumination is related to a risk of relapse. Nolen-
Hoeksema (2000) found in her study that ruminative responses was correlated with 
depressive symptoms one year later, as well as with a depression diagnosis, though the 
effect on depression diagnosis was not significant when controlling for baseline 
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depression severity. A study by Michalak and colleagues (2011) showed that after going 
through mindfulness-based cognitive therapy, the subjects self-reported rumination 
predicted relapse, even when controlling for level of depressive symptoms and previous 
number of episodes. A study examining relapse risk factors in patients with comorbid 
avoidant personality disorder and MDD found that rumination was associated with 
personality pathology and increased risk of relapse in this population (van Rijsbergen, 
Kok, Elgersma, Hollon & Bockting, 2015). Huffziger and associates (2009) found in 
their longitudinal study of formerly depressed patients that ruminative symptom-focus 
predicted depressive symptoms over a period of three and a half years. Longitudinal 
studies on adolescents have found that high rumination can predict higher levels of 
depressive symptoms, increase in depressive symptoms and future symptoms (Calvete, 
Orue & Hankin, 2015; Wilkinson, Croudace & Goodyer, 2013). As mentioned 
previously, there are no studies that have investigated whether impairment in executive 
functioning and high self-reported rumination is related to an increased risk of relapse. 
Several studies, including those mentioned above, have investigated these variables, but 
not together. Even though our model was not able to predict a risk of relapse at T3, 
based on data from T2, RRS sum score and RRQ rumination were the variables with the 
highest odd’s ratio in our model, and it appears that these are of more relevance when it 
comes to risk of relapse five years after the first depressive episode.  
Strengths and Limitations 
It has previously been mentioned that there is a lack of longitudinal research on 
depression in general, which makes this study, with its ten-year perspective, an 
important addition to the current literature. Another strength of this study is that the 
patient group consists of subjects who at T1 were going through their first episode of 
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depression. This provides a unique opportunity to study how initial impairments in 
inhibition and tendencies to ruminate develop in the years following onset.  
 This study also uses a patient group as opposed to inducing sad mood in healthy 
individuals, which has been the case in several other investigations of rumination. It is 
our opinion that using depressed individuals when studying rumination and inhibition 
increases the clinical relevance of our findings compared to studies using e.g. college 
students. In addition, this study did not induce rumination, but rather measured trait 
rumination through questionnaires. We believe that this is a more relevant procedure 
when looking at change in ruminative tendencies over time. 
There are a few noteworthy limitations to the present study. The one that is perhaps 
the most pressing is the relatively small sample size. At the five-year follow-up, the 
patient group was reduced to 23 individuals, the no-relapse group consisting of merely 
six subjects. This reduces the power of the statistical analyses performed and therefore 
increases the risk of making a type II error when interpreting the results. As mentioned 
earlier, attempts were made to compensate for this by setting a more lenient alpha-level 
for the analyses with the patient subgroups. This adjustment did not have any effect on 
the findings. The low number of subjects still makes it important to use caution when 
interpreting the results.  
 Another aspect that is important to note is that the full-scale RRS was used in all 
analyses in this study. As previously stated, Schoofs and associates (2010), Treynor, 
and colleagues (2003) and several other researchers have found evidence that there are 
two dimensions in the RRS, and that the “brooding” dimension, compared to the 
“reflection” subcomponent, is most strongly associated with depressive symptoms. 
Treynor and associates (2003) recommend that researchers using the current version of 
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RRS separate their results into the brooding and reflection sub-components, but also 
note that this could lead to difficulties in analysis due to the relatively few items on each 
dimension. The results show that the full-scale RRS was strongly correlated with the 
RRQ-rumination measure, and we thus concluded that it was justified to continue 
analyses without dividing the scale into brooding and reflection.  
 Demographically, the participants in this study differ from the average 
population on intelligence level, the average IQ of both patient group and control group 
being ≈119 at T3. Hence, it is possible that the findings are not applicable to a 
population of average or below-average intelligence. The subjects are also relatively 
young, which might mean that the results are not generalizable to an older population. 
Haddad and Gunn (2011) state that the age of onset for depression ranges between 19 
and 44 years, with an average age of onset of 32 years. The average age of the 
participants in this study (≈26 in both groups at T1) is well within the above-mentioned 
range, but is somewhat lower than the average age of onset.   
Clinical Implications 
The findings in the present study indicate that the two measures on rumination 
used in this study, RRS and RRQ-rumination, are strongly correlated. It therefore 
appears that these questionnaires measure the same tendencies. The strong correlation 
between RRS and RRQ indicates that both these questionnaires can be used as 
assessment tools for clinicians when planning effective treatment programs for 
depressive disorders.  
Further, the difference found between the groups on rumination and cognitive 
inhibition, as well as the correlation between rumination and cognitive inhibition, 
indicates that those who tend to ruminate also show impaired cognitive inhibition. Since 
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these findings replicate those from T1 and T2, it supports the hypothesis mentioned in 
the literature that rumination is indeed a trait-like construct. It is important for therapists 
to treat rumination as a stable trait, and if a patient shows high rumination in initial 
depressive episodes this is likely to persist despite symptom reduction. 
Results showed significant correlations between cognitive inhibition and 
rumination for all subjects. Since this relationship was found for all subjects, it indicates 
that this pattern is not only valid for depressed patients, but also for healthy controls. 
This is in accordance with the previously mentioned findings that rumination is a trait-
like construct that is also present in healthy controls, though not to the same extent as in 
depressed individuals. Assessing rumination might be important in low-threshold 
intervention programs and in prevention of depression in at-risk populations. The 
healthy controls showing the pattern of high rumination and poorer cognitive inhibition 
might be at risk for developing a depressive episode, for example after experiencing 
negative events or a life crisis.   
Conclusions and Closing Remarks 
In this study we posited hypotheses regarding the effect of rumination and 
cognitive inhibition on first episode depressed patients and healthy controls, and the 
relationship between these variables on the risk of experiencing recurrent depressive 
episodes. In conclusion, the results show that depressed individuals perform poorer on 
measures of cognitive inhibition than the control group, as well as reporting higher 
levels of self-reported trait rumination. There was found a correlation between cognitive 
inhibition and self-reported a rumination, when investigating all subjects, where a 
higher score on the rumination measures is associated with a slower response on the 
more demanding cognitive inhibition tasks.  The hypothesis regarding that poor 
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performance on CWIT and high self-reported rumination would be able to predict 
relapse in the patient group, was not supported. The results have not been able to 
demonstrate significant differences between the relapse groups and the no-relapse 
group, which might be a result of low power in the sample size.   
 This study strengthens previous findings on the topic of rumination, which 
across different studies have found impairment in inhibition and/or mental flexibility in 
high ruminators, both in a clinical and random sample. We argue that our study is an 
important contribution to this research, as it is the first to investigate this relationship 
over a longer time-span, by testing a clinical sample five years after initial depressive 
episode.   
 Based on the results, some lines for further research are suggested. For future 
studies, we recommend conducting more longitudinal studies on a clinical sample of 
first-episode depressed individuals, given that such a high percentage experience relapse 
after their first depressive episode. This would make future research more generalizable 
in the depressive population, and increase its relevance for clinical real-life situations. In 
the present study, there was a high dropout rate from T1 to T3, affecting the power in 
the study. One could avoid this by using a larger sample size if possible, considering 
that dropouts are to be expected over such a long period of time. As previously 
discussed, non-clinical subjects with higher levels of rumination and slower response 
time on cognitive inhibition tasks may contribute to the correlation between cognitive 
inhibition and self-reported inhibition. This relationship can be interesting for future 
research investigating vulnerability for depression.  
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